SCHEMBL21290225

SCHEMBL21290225

Cc1ccc(-c2ccc(CCc3cc(CCc4ccc(-c5ccc(C)cn5)cc4)cc(-c4ccccc4-c4ccc(-c5cc(-c6ccc(-c7ccccc7)cc6C)c(C)cn5)cc4)c3)cc2)nc1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CYP3A4 P08684 2/20 0.38
BRS3 P32247 10/20 0.38
LDHA P00338 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
FFAR1 O14842 1/20 0.34
CYP2A6 P11509 1/20 0.34
P2RX7 Q99572 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23956294 0.89 LDHA (0.40) CYP11B1CYP11B2CYP3A4LDHAMEN1
SCHEMBL25100598 0.88 CYP11B1 (0.42) CYP11B1CYP11B2CYP3A4BRS3LDHA
SCHEMBL25100976 0.86 CYP11B1 (0.42) CYP11B1CYP11B2CYP3A4BRS3MEN1
SCHEMBL25100532 0.86 CYP11B1 (0.42) CYP11B1CYP11B2CYP3A4BRS3MEN1
SCHEMBL25100925 0.86 CYP11B1 (0.42) CYP11B1CYP11B2CYP3A4BRS3MEN1
SCHEMBL25100594 0.84 CYP11B1 (0.42) CYP11B1CYP11B2CYP3A4LDHAPDCD1
SCHEMBL21290192 0.83 BRS3 (0.38) CYP11B1CYP11B2CYP3A4BRS3CYP2A6
SCHEMBL25100830 0.82 CYP11B1 (0.38) CYP11B1CYP11B2CYP3A4BRS3MEN1
SCHEMBL21289928 0.81 BRS3 (0.38) CYP11B1CYP11B2CYP3A4BRS3
SCHEMBL25100887 0.78 RAB9A (0.42) CYP11B1CYP11B2CYP3A4BRS3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752512-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-03-01 EP disclosed
WO-2019158453-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-08-22 WO disclosed